Ruohong Shui

815 total citations
13 papers, 119 citations indexed

About

Ruohong Shui is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ruohong Shui has authored 13 papers receiving a total of 119 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ruohong Shui's work include Breast Cancer Treatment Studies (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Cancer Cells and Metastasis (4 papers). Ruohong Shui is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Cancer Cells and Metastasis (4 papers). Ruohong Shui collaborates with scholars based in China. Ruohong Shui's co-authors include Wentao Yang, Miao Ruan, Tian Tian, Wenjuan Tian, Baohua Yu, Xiaoli Xu, Chen Chen, Zhi‐Ming Shao, Ceshi Chen and Junjie Li and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Oncotarget and Breast Cancer Research.

In The Last Decade

Ruohong Shui

13 papers receiving 117 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruohong Shui China 5 84 31 30 20 17 13 119
Jorge Dunstan Peru 7 132 1.6× 33 1.1× 44 1.5× 27 1.4× 31 1.8× 17 163
Carolien Bierman Netherlands 5 91 1.1× 43 1.4× 24 0.8× 10 0.5× 22 1.3× 9 104
Wuliang Wang China 8 47 0.6× 53 1.7× 28 0.9× 33 1.6× 68 4.0× 28 201
Justin Harold United States 8 73 0.9× 37 1.2× 33 1.1× 32 1.6× 48 2.8× 18 186
N A Oleynikova Russia 6 91 1.1× 19 0.6× 18 0.6× 14 0.7× 23 1.4× 28 131
Caddie Laberiano-Fernández United States 7 77 0.9× 16 0.5× 51 1.7× 9 0.5× 58 3.4× 15 158
Sarah Reinke Germany 8 69 0.8× 23 0.7× 41 1.4× 9 0.5× 20 1.2× 22 154
Angelika Kaufmann United Kingdom 8 93 1.1× 30 1.0× 11 0.4× 11 0.6× 92 5.4× 14 207
Christiane Kuempers Germany 6 43 0.5× 21 0.7× 15 0.5× 17 0.8× 40 2.4× 14 113
Takashi Mineo Japan 4 85 1.0× 30 1.0× 43 1.4× 24 1.2× 37 2.2× 12 168

Countries citing papers authored by Ruohong Shui

Since Specialization
Citations

This map shows the geographic impact of Ruohong Shui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruohong Shui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruohong Shui more than expected).

Fields of papers citing papers by Ruohong Shui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruohong Shui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruohong Shui. The network helps show where Ruohong Shui may publish in the future.

Co-authorship network of co-authors of Ruohong Shui

This figure shows the co-authorship network connecting the top 25 collaborators of Ruohong Shui. A scholar is included among the top collaborators of Ruohong Shui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruohong Shui. Ruohong Shui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Wang, Han, Chenglin Liu, Yi Xiao, et al.. (2023). Genomic alterations affecting tumor-infiltrating lymphocytes and PD-L1 expression patterns in triple-negative breast cancer. JNCI Journal of the National Cancer Institute. 115(12). 1586–1596. 6 indexed citations
3.
Zhu, Ping, et al.. (2023). [Efficacy of neoadjuvant therapy on HER2-positive breast cancer: a clinicopathological analysis].. PubMed. 52(9). 907–911. 1 indexed citations
4.
Chen, Chen, et al.. (2022). Concordance of PD-L1 expression in triple-negative breast cancers in Chinese patients: A retrospective and pathologist-based study. Pathology - Research and Practice. 238. 154137–154137. 2 indexed citations
5.
Cheng, Jingyi, et al.. (2021). Diagnostic performance of a novel high-resolution dedicated axillary PET system in the assessment of regional nodal spread of disease in early breast cancer. Quantitative Imaging in Medicine and Surgery. 12(2). 1109–1120. 4 indexed citations
6.
Zhu, Xinyi, Tian Tian, Miao Ruan, et al.. (2018). Expression of DNA Damage Response Proteins and Associations with Clinicopathologic Characteristics in Chinese Familial Breast Cancer Patients with BRCA1/2 Mutations. Journal of Breast Cancer. 21(3). 297–297. 4 indexed citations
7.
Shui, Ruohong, et al.. (2018). [Clinicopathologic features of breast lymphoma in core needle biopsy].. PubMed. 47(10). 737–742. 1 indexed citations
8.
Ruan, Miao, Tian Tian, Xiaoli Xu, et al.. (2018). Predictive value of tumor-infiltrating lymphocytes to pathological complete response in neoadjuvant treated triple-negative breast cancers. Diagnostic Pathology. 13(1). 66–66. 36 indexed citations
9.
10.
Shui, Ruohong, Baohua Yu, Rui Bi, Fei Yang, & Wentao Yang. (2016). An interobserver reproducibility analysis of ki67 visual assessment in breast cancer. Pathology. 48. S155–S156. 1 indexed citations
11.
Tian, Tian, Miao Ruan, Wentao Yang, & Ruohong Shui. (2016). Evaluation of the prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers. Oncotarget. 7(28). 44395–44405. 24 indexed citations
12.
Li, Ting, Minhao Fan, Ruohong Shui, et al.. (2014). Pathology-Confirmed Granuloma Mimicking Liver Metastasis of Breast Cancer. The International Journal of Biological Markers. 29(1). e93–e97. 1 indexed citations
13.
Tian, Wenjuan, et al.. (2011). Prognostic factors and treatment comparison in early-stage small cell carcinoma of the uterine cervix. Oncology Letters. 3(1). 125–130. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jorge Dunstan Breakdown of academic impact, for papers by Carolien Bierman Breakdown of academic impact, for papers by Wuliang Wang Breakdown of academic impact, for papers by Justin Harold Breakdown of academic impact, for papers by N A Oleynikova Breakdown of academic impact, for papers by Caddie Laberiano-Fernández Breakdown of academic impact, for papers by Sarah Reinke Breakdown of academic impact, for papers by Angelika Kaufmann Breakdown of academic impact, for papers by Christiane Kuempers Breakdown of academic impact, for papers by Takashi Mineo
Rankless by CCL
2026